Key features and details | |
Cat. No. | MABL-1616 |
Name | Anti-FLT3 mAbs |
Clone No. | AFD- NC7 |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | SPR, ELISA, FC |
Species Reactivity | Human |
Basic Information | |
Specificity | The antibody binds an epitope within domain D5 of human FLT3. |
Alternative Name | FLK-2; FLT-3; STK-1; CD135; Fetal liver kinase 2; FL cytokine receptor; stem cell tyosine kinase 1; Fms-like tyrosine kinase 3; Receptor-type tyrosine-protein kinase FLT3 |
UniProt | P36888 |
Immunogen | The original Fab antibody was isolated from a human Fab phage display by selection of a high affinity antibody binding to the human FLT3. |
Application Notes | The clone was shown to selectively bind to human FLT3 with high affinity and block FL binding. The ability of the antibody to bind the receptor was examined by ELISA (EC50= 0.3 nM). The ability of the antibody to block receptor-ligand binding was examined in a FL binding competition ELISA, the antibody blocked the binding of FL to FLT3 with a IC50 within the range of 0.8 nM. The clone binds FLT3 with an affinity of 0.45 nM as determined by surface plasmon resonance (SPR). The in vivo efficacy of the clone was determined in SEM-K2 cells, a human ALL cell line expressing wild type FLT3. In comparison to human IgG, the clone treatment all significantly prolonged survival in the SEM-K2 leukemia model (US8071099B2). |
Antibody First Published | Li et al. Anti-FLT3 antibodies |
Note on publication | The patent describes a fully human antibody which specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity |
COA Information (For reference only, actual COA shall prevail) | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |